This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Daniel Horner
Introduction
Daniel Horner is an accomplished inventor based in Loughborough, GB. He has made significant contributions to the field of chemistry, particularly in the preparation of sulfonyl chloride derivatives. His work has implications for various applications in pharmaceuticals and chemical synthesis.
Latest Patents
Horner holds a patent for a novel process to prepare hydantoin sulfonyl chlorides. This patent, titled "Process to prepare sulfonyl chloride derivatives," discloses a method for synthesizing compounds of general formula (I), where R and n are specified in the description. The patent also includes certain novel intermediates that are crucial for the synthesis process. He has 1 patent to his name.
Career Highlights
Daniel Horner is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development in the field of chemical processes, where he applies his expertise to innovate and improve existing methodologies.
Collaborations
Horner collaborates with Philip Cornwall, a fellow researcher at AstraZeneca AB. Together, they work on advancing chemical processes and exploring new avenues for innovation in their field.
Conclusion
Daniel Horner's contributions to the field of chemistry, particularly through his patent on sulfonyl chloride derivatives, highlight his innovative spirit and dedication to advancing scientific knowledge. His work at AstraZeneca AB and collaboration with colleagues further exemplify his commitment to excellence in research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile